Invivyd, Inc. (IVVD)
(Delayed Data from NSDQ)
$0.80 USD
+0.04 (5.88%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.80 0.00 (0.26%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Invivyd, Inc. has a market cap of $90.40M, which represents its share price of $0.75 multiplied by its outstanding shares number of 119.96M. As a small-cap company, IVVD's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
IVVD 0.80 +0.04(5.88%)
Will IVVD be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for IVVD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IVVD
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates
Royalty Pharma (RPRX) Tops Q2 Earnings and Revenue Estimates
IVVD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Invivyd, Inc. (IVVD) Reports Q1 Loss, Lags Revenue Estimates
Invivyd, Inc. (IVVD) Reports Q4 Loss, Tops Revenue Estimates
Are Investors Undervaluing Invivyd, Inc. (IVVD) Right Now?
Other News for IVVD
Invivyd (IVVD) Welcomes New Expert to SPEAR Study Group | IVVD Stock News
Scientist Dr. Akiko Iwasaki Joins SPEAR Study Group to Investigate Monoclonal Antibodies for ...
Invivyd announces addition of Iwasaki to SPEAR Study Group
Invivyd (IVVD) Gains Momentum with New Monoclonal Antibody Guidelines | IVVD Stock News